Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Int J Gynecol Cancer. 2015 Jul;25(6):1015–1022. doi: 10.1097/IGC.0000000000000453

Table 2.

Univariate Analysis of Clinicopathologic Factors and Chemotherapy Response

HR 95% CI P
Patient Characteristics
  Age 1.00 0.97, 1.02 0.75
  BMI 0.98 0.95, 1.01 0.2
  Race* 0.83 0.37, 1.87 0.65
  Radiation therapy± 0.49 0.27, 0.87 0.02
  Serum Platelet Level 2.80 1.46, 5.38 <0.01
  Serum CA-125 Level 1.01 1.00,1.03 0.03
Tumor Characteristics
  FIGO Stage 2.48 1.32, 4.65 <0.01
  Grade 4.88 1.47, 16.13 0.01
  LVSI 1.81 0.93, 3.51 0.08
  Histology 1.11 0.62, 1.97 0.73
*

white versus black/other

±

Received radiation versus none (includes EBRT, vaginal brachytherapy, or combination of both)

Analyzed as continuous variable